Silo

The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube

Retrieved on: 
Monday, January 29, 2024
ASG, TFX, Silo, Patent, United, Health, Antibiotics

CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.

Key Points: 
  • CARLSBAD, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 11,832,853 entitled “Hybrid Radiolucent Surgical Operating Tube”.
  • Aurora Spine’s Ghost Tube™ was designed to provide superior anchoring with a translucent thermoplastic body and non-slipping titanium anchors to assure that minimally invasive surgical access will stay stationary to support surgical preparation tools without blocking x-ray visualization during surgery.
  • "Aurora Spine has created several disruptive technologies in the past 12 years”, said Trent Northcutt, President & CEO of Aurora Spine. "
  • Aurora will continue being disruptive and innovative by looking at ways to efficiently deliver our products and create and improve new treatment options to improve patient care and overall patient outcomes.”

AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING

Retrieved on: 
Thursday, January 18, 2024
ASG, Patient, Silo, Synovial joint, TFX, Journal, Sacroiliac joint, Physician

CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada.

Key Points: 
  • CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada.
  • The NANS Annual Meeting is a prominent medical conference that brings together healthcare professionals, researchers, and experts in the field of neuromodulation.
  • Aurora will be showcasing two Sacroiliac Joint (SI Joint) fusion products.
  • Silo TFX and Silo offer physicians options to stabilize the SI Joint, helping patients with access to treatment for their SI joint dysfunction.

Silo Pharma and Partner Receive Regulatory Approval to Begin Development of Ketamine Implant for Fibromyalgia

Retrieved on: 
Thursday, December 28, 2023
DEA, Silo, Ketamine, Chronic pain, Therapy, SILO, Fibromyalgia

SARASOTA, FL, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or “the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced an update on its dosage and time-release ketamine-loaded implant, designated as SP-26, which is being developed as a potential at-home pain relief treatment for fibromyalgia and other chronic pain conditions. In collaboration with Sever Pharma Solutions, Silo’s contract development and manufacturing partner, SP-26 is advancing through analytical testing and small batch pre-clinical proof of concept extrusion trials to determine drug release and stability.

Key Points: 
  • In collaboration with Sever Pharma Solutions, Silo’s contract development and manufacturing partner, SP-26 is advancing through analytical testing and small batch pre-clinical proof of concept extrusion trials to determine drug release and stability.
  • Silo intends to pursue the FDA’s streamlined 505(b)(2) pathway for approval of SP-26.
  • Eric Weisblum, Chief Executive Officer of Silo Pharma, commented “Many chronic pain sufferers are seeking a non-opioid treatment that offers relief.
  • Based on findings to date, we believe SP-26 has the potential to be the first at-home approved ketamine treatment for chronic pain including fibromyalgia.”

MONTRÉAL EN LUMIÈRE 2024

Retrieved on: 
Tuesday, December 5, 2023
Air France, City, Heart, Silo, Food, La Presse, Food court, Restaurant, Kyujiro Saito, Cooking, Wine, Scotiabank, Loonie, MENU, Polestar, History, Substance, Life, Meal, Bell, SAQ, Aliment, Table, Gastronomy, Kronos Quartet, Music, Partnership, Nuit, Sale, Glass, Wind, Mõrdu, Reindeer, Drink, LE, Pretty Woman

Montréal, Dec. 05, 2023 (GLOBE NEWSWIRE) -- MONTRÉAL EN LUMIÈRE, presented by Loto-Québec in collaboration with Scotiabank, invites you to its sparkling 25th anniversary edition.

Key Points: 
  • Montréal, Dec. 05, 2023 (GLOBE NEWSWIRE) -- MONTRÉAL EN LUMIÈRE, presented by Loto-Québec in collaboration with Scotiabank, invites you to its sparkling 25th anniversary edition.
  • A trailblazer festival, MONTRÉAL EN LUMIÈRE offers all kinds of ways to play outside and make the most of winter.
  • "The MONTRÉAL EN LUMIÈRE festival is the spark plug that has kept the city shining bright for 25 years!
  • "Get your wool socks and long johns out, get ready to smile, and come and have a great time at MONTRÉAL EN LUMIÈRE.

Aurora Spine Corporation Announces Third Quarter Fiscal 2023 Financial Results

Retrieved on: 
Wednesday, November 15, 2023
ASG, ZIP, TFX, Earnings, Marketing, Silo, Synovial joint, Growth, Physician, Interest, Cryptocurrency, Rare-earth element, Video game, Q3, Depreciation, Q4

CARLSBAD, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its third quarter fiscal 2023 ended September 30, 2023. All figures are in U.S. dollars.

Key Points: 
  • Management to host conference call for investors in coming week, details to follow -
    CARLSBAD, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the financial results for its third quarter fiscal 2023 ended September 30, 2023.
  • Full Release of SiLO TFX – With over 35 instrument sets release to the sales team, SiLO TFX sales increased 51% quarter over quarter making up 30.5% of sales in Q3 2023.
  • Mr. Trent Northcutt, President and Chief Executive Officer of Aurora Spine, stated, “We are pleased with our third quarter’s results.
  • Total operating expenses were $2.607 million for the third quarter of 2023, compared to $2.058 million in the third quarter of 2022.

Lightspeed announces global rollout of its ‘Meet or Beat Promise’ as part of its Unified Payments & POS initiative

Retrieved on: 
Monday, October 30, 2023
Unified Payments Interface, Meal, Silo, Payment, NYSE, JD, Fraud, IPhone, Risk, Travel, Saint Martin, TSX, POS, Cryptocurrency, Online shopping, Retail, Audit, Speed of light

In April 2023, the Company announced the launch of its unified Lightspeed Payments & POS platform, asking all eligible customers to sign up for its one cohesive and comprehensive product offering, which sees Lightspeed Payments embedded directly into their POS.

Key Points: 
  • In April 2023, the Company announced the launch of its unified Lightspeed Payments & POS platform, asking all eligible customers to sign up for its one cohesive and comprehensive product offering, which sees Lightspeed Payments embedded directly into their POS.
  • “Now feels like the right time to roll out our ‘Meet or Beat Promise’ globally,” explained JD Saint-Martin, President of Lightspeed.
  • “We’ve heard great feedback from customers who see tangible benefits to their business by adopting Lightspeed Payments and POS.
  • Eligible customers who switch to Lightspeed Payments will also unlock benefits such as:
    Powerful insights into how to optimize their business.

Lightspeed announces global rollout of its ‘Meet or Beat Promise’ as part of its Unified Payments & POS initiative

Retrieved on: 
Monday, October 30, 2023
Unified Payments Interface, Meal, Silo, Payment, NYSE, JD, Fraud, IPhone, Risk, Travel, Saint Martin, TSX, POS, Online shopping, Cryptocurrency, Retail, Audit, Speed of light

In April 2023, the Company announced the launch of its unified Lightspeed Payments & POS platform, asking all eligible customers to sign up for its one cohesive and comprehensive product offering, which sees Lightspeed Payments embedded directly into their POS.

Key Points: 
  • In April 2023, the Company announced the launch of its unified Lightspeed Payments & POS platform, asking all eligible customers to sign up for its one cohesive and comprehensive product offering, which sees Lightspeed Payments embedded directly into their POS.
  • “Now feels like the right time to roll out our ‘Meet or Beat Promise’ globally,” explained JD Saint-Martin, President of Lightspeed.
  • “We’ve heard great feedback from customers who see tangible benefits to their business by adopting Lightspeed Payments and POS.
  • Eligible customers who switch to Lightspeed Payments will also unlock benefits such as:
    Powerful insights into how to optimize their business.

AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING

Retrieved on: 
Monday, October 23, 2023
Aurora, ASG, Person, TSX Venture Exchange, CDN, Silo, Multilateral, Minority, ZIP, MI, Legislation, News, Offering, Growth, TSX, TFX, Security (finance)

Carlsbad, California, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE: ASG) (OTCQB: ASAPF) is pleased to announce that it has completed a non-brokered private placement offering of units ("Units") for gross proceeds of approximately CDN$1.9 million (the "Offering").

Key Points: 
  • Carlsbad, California, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE: ASG) (OTCQB: ASAPF) is pleased to announce that it has completed a non-brokered private placement offering of units ("Units") for gross proceeds of approximately CDN$1.9 million (the "Offering").
  • Each Unit is comprised of one common share of the Company and one common share purchase warrant of the Company.
  • Each whole warrant is exercisable at a price of CDN$0.50 per common share for a period of 24 months following the date of issuance.
  • Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

EQS-News: USU listed in the Gartner® Market Guide for Software Asset Management Tools 2023

Retrieved on: 
Tuesday, October 17, 2023
ECC, SAM, Microsoft, Software asset management, Engineering, IBM, Organization, Risk, SAP, Software as a service, Product management, USU, Silo, Oracle, Research, Publication, Risk management, Software, Asset management, Private investigator, Cryptocurrency, Gartner

Research firm Gartner® has released the “Market Guide for Software Asset Management Tools 2023”, in which USU is listed as a Representative Vendor.

Key Points: 
  • Research firm Gartner® has released the “Market Guide for Software Asset Management Tools 2023”, in which USU is listed as a Representative Vendor.
  • USU Software Asset Management is one of a few SAM tool providers to cover all categories.
  • The Gartner report "Market Guide for Software Asset Management Tools," published on October 3rd, 2023, by analysts Jaswant Kalay, Ciaran Hudson, and Yolanda Harris, is available at www.usu.com .
  • Gartner, Market Guide for Software Asset Management Tools, October 3, 2023.

Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System

Retrieved on: 
Wednesday, September 13, 2023
Aurora, ASG, Silo, Sacrum, Ilium, TFX, Sacroiliac joint, Engineering, Marketing, Operation

Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it is in full commercial release of its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Device system.

Key Points: 
  • Carlsbad, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, announced today that it is in full commercial release of its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Device system.
  • The patented, minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.
  • The SiLO TFX MIS Sacroiliac Joint Fixation System includes a Transfixing-Cone, an ilium screw, a sacrum screw and associated instrumentation.
  • I am pleased with the teamwork between Engineering, Operations and Marketing on the full release of the SiLO TFX system."